Skip to main content
. 2021 Oct 15;48(1):176–189. doi: 10.1093/schbul/sbab103

Table 4.

Recommendations on the Management of Clozapine-Withdrawal-Induced Catatonia

Recommendations Type Level of Evidence Strength of Recommendation
Avoid abrupt discontinuation of clozapine to minimise risk of clozapine-withdrawal-induced catatonia Consensus based - -
If feasible, re-initiate clozapine Evidence-based (III) evidence from non-experimental descriptive study (C) Directly based on category III evidence
Consider benzodiazepine as an adjunctive treatment Evidence-based (III) evidence from non-experimental descriptive study (C) Directly based on category III evidence
Where re-initiation of clozapine or use of benzodiazepines is not feasible, consider ECT Evidence-based (III) evidence from non-experimental descriptive study (C) Directly based on category III evidence